MEF2B and neoplasm: Given that IGF2BP3 is known to influence this microenvironment (Liu et al., 2023), we are analyzing prognostic models’ impact on KIRC immunity to assess the roles of IGF2BP3, CENPA, and MEF2B axis as a whole factor in tumor immunity.